Showing results (3761-3770 of 27,715) with videos related to
Sort By:
Pageof 2,772
Vaccine|February 10, 2007
The identification of surface proteins of Burkholderia pseudomalleiSarah V Harding, Mitali Sarkar-Tyson, Sophie J Smither, et al.Vaccine|February 10, 2007
Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virusWei-Gang Hu, Damon Chau, Josh Wu, et al.Vaccine|February 13, 2007
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescentsAndrea Gabbuti, Luisa Romanò, Pierluigi Blanc, et al.Vaccine|February 13, 2007
Development of a recombinant vaccine against aerosolized plagueStephen R MorrisVaccine|February 13, 2007
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screeningM Adams, B Jasani, A FianderVaccine|February 13, 2007
Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivoChristine M Malboeuf, David A L Simon, Young-Eun Ellen Lee, et al.Vaccine|February 13, 2007
Protection against anthrax by needle-free mucosal immunization with human anthrax vaccineMingtao Zeng, Qingfu Xu, Michael E PichicheroVaccine|February 14, 2007
Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infectionA I Mallick, H Singha, P Chaudhuri, et al.Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.Vaccine|April 3, 2007
Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trialsJitendra N Mehrishi, Miklós Szabó, Tibor BakácsPageof 2,772